US2005186254A1PendingUtilityA1

Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby

Assignee: ELAN DRUG DELIVERY LTDPriority: Jun 7, 1995Filed: Mar 15, 2005Published: Aug 25, 2005
Est. expiryJun 7, 2015(expired)· nominal 20-yr term from priority
Y02A50/30A61K 9/2018C12N 1/04A61K 9/2095
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides methods for producing foamed glass and the compositions obtained thereby. The compositions are suitable for stable storage of a wide variety of substances, particularly biological and pharmaceutical.

Claims

exact text as granted — not AI-modified
1 - 77 . (canceled)  
     
     
         78 . A pharmaceutical composition comprising a foamed glass matrix.  
     
     
         79 . A pharmaceutical composition comprising at least one substance incorporated into foamed glass matrices (FGMs).  
     
     
         80 . A composition obtainable by reconstituting the foamed glass matrices of  claim 79 .  
     
     
         81 . The composition according to  claim 79 , wherein the substance is a bioactive substance.  
     
     
         82 . A composition obtainable by reconstituting the foamed glass matrices (FGMs) of  claim 81 .  
     
     
         83 . A composition comprising a foamed glass matrix and a therapeutic or diagnostic agent incorporated within the matrix, wherein the agent is an organic molecule or a virus.  
     
     
         84 . A composition comprising a foamed glass matrix and a therapeutic or diagnostic agent incorporated within the matrix, wherein the matrix is formed from a carbohydrate.  
     
     
         85 . A composition according to  claim 84 , wherein the agent is a cell or bacterial microorganism  
     
     
         86 . A composition according to  claim 83  wherein the agent is a virus.  
     
     
         87 . A composition according to  claim 84 , wherein the agent is a virus.  
     
     
         88 . A composition according to  claim 83 , wherein the agent is a protein, peptide or nucleic acid.  
     
     
         89 . A composition according to  claim 84 , wherein the agent is a protein, peptide or nucleic acid.  
     
     
         90 . A composition according to  claim 83  wherein the foamed glass matrix is formed from a stabilizing polyol.  
     
     
         91 . A composition according to  claim 86  wherein the foamed glass matrix is formed from a stabilizing polyol.  
     
     
         92 . A composition according to  claim 88  wherein the foamed glass matrix is formed from a stabilizing polyol.  
     
     
         93 . A composition according to  claim 90 , wherein the stabilizing polyol is a carbohydrate.  
     
     
         94 . A composition according to  claim 91  wherein the stabilizing polyol is a carbohydrate.  
     
     
         95 . A composition according to  claim 92  wherein the stabilizing polyol is a carbohydrate.  
     
     
         96 . A composition according to any of  claims 78  to  95 , wherein the matrix is formed from glucose, sucrose or lactose.  
     
     
         97 . A composition according to any of  claims 78  to  95 , wherein the matrix is formed from trehalose.  
     
     
         98 . A composition comprising a foamed glass matrix and, incorporated within the matrix, a therapeutic or prophylactic agent, wherein the agent is a virus; a lipid; an organic; a synthetic protein or peptide; a natural or synthetic protein or peptide selected from: an enzyme, a growth hormone, a growth factor, insulin, an antibody, an interferon, an interleukin or a cytokine; a peptide mimetic; a hormone; a D or L amino acid polymer; an oligosaccharide; a polysaccharide; a nucleotide; an oligonucleotide; a nucleic acid; a protein nucleic acid hybrid; or a small molecule and physiologically active analogues thereof.  
     
     
         99 . A composition comprising a foamed glass matrix and, incorporated within the matrix, a therapeutic or prophylactic agent, wherein the matrix is formed from a carbohydrate selected from: a monosaccharide, a disaccharide selected from maltose, iso-maltose, lactose, maltulose, iso-maltulose, lactulose, sucrose, cillibiose and mannobiose, a trisaccharide, a sugar alcohol, an oligosaccharide or its corresponding sugar alcohol, a carbohydfrate derivative, a chemically modified carbohydrate, hydroxyethyl starch, a sugar copolymer, a synthetic carbohydrate or a straight chain polyalcohol.

Join the waitlist — get patent alerts

Track US2005186254A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.